Abstract | BACKGROUND: MATERIALS AND METHODS: This was a secondary analysis of a prospective observational trial in cardiac surgery patients admitted to the Intensive Care Unit of a university hospital in the Netherlands. Fourteen TRALI cases were randomly matched with 32 transfused and non-transfused controls. Pulmonary levels of HMGB1, S100A12 and inflammatory cytokines ( interleukins-1β, -6, and -8 and tumour necrosis factor-α) were determined when TRALI evolved. In addition, systemic and pulmonary levels of soluble receptor for advanced glycation end products (sRAGE) were determined. RESULTS: CONCLUSION:
|
Authors | Marcella C A Müller, Pieter R Tuinman, Alexander P Vlaar, Anita M Tuip, Kelly Maijoor, Achmed Achouiti, Cornelis Van t Veer, Margreeth B Vroom, Nicole P Juffermans |
Journal | Blood transfusion = Trasfusione del sangue
(Blood Transfus)
Vol. 12
Issue 3
Pg. 368-75
(Jul 2014)
ISSN: 2385-2070 [Electronic] Italy |
PMID | 24887223
(Publication Type: Comparative Study, Journal Article, Observational Study, Randomized Controlled Trial)
|
Chemical References |
- Cytokines
- HMGB1 Protein
- HMGB1 protein, human
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic
- S100 Proteins
- S100A12 Protein
- S100A12 protein, human
|
Topics |
- Acute Lung Injury
(blood, etiology)
- Aged
- Aged, 80 and over
- Cardiac Surgical Procedures
- Cardiopulmonary Bypass
(adverse effects)
- Cytokines
(blood)
- Female
- HMGB1 Protein
(blood)
- Humans
- Male
- Middle Aged
- Pneumonia, Ventilator-Associated
(blood)
- Prospective Studies
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic
(blood)
- Respiratory Distress Syndrome
(blood, etiology)
- S100 Proteins
(blood)
- S100A12 Protein
- Transfusion Reaction
|